USFDA gives nod for generic Naproxen Sodium Softgel Capsules

It is bioequivalent and therapeutically equivalent to the reference-listed drug, naproxen sodium capsules, 220 mg of Bionpharma Inc, it added.

234
USFDA Approval
USFDA Approval

Last Updated on October 10, 2024 by The Health Master

Strides Pharma Science Ltd said its wholly-owned arm, Strides Pharma Global Pte Ltd, has received approval from the US health regulator for generic naproxen sodium softgel capsules, used to treat pain or inflammation.

The approval by the US Food & Drug Administration (USFDA) is for naproxen sodium softgel capsules of 220 mg strength (over the counter), the company said in a regulatory filing.

It is bioequivalent and therapeutically equivalent to the reference-listed drug, naproxen sodium capsules, 220 mg of Bionpharma Inc, it added.

The product will be manufactured at the company’s Bengaluru facility.

Naproxen sodium softgel capsules are a nonsteroidal anti-inflammatory drug used to treat pain or inflammation caused by conditions such as arthritis, ankylosing spondylitis, tendinitis, bursitis, gout, or menstrual cramps, the company said.

Strides said it is focusing on building a private label business in the US by leveraging its portfolio of products across soft gels, tablets, capsules, and other formats.

The US over-the-counter (OTC) market for naproxen sodium softgel capsules, 220 mg, is approximately USD 100 million, the company said.

USFDA gives approval for Rufinamide tablets

USFDA approves generic Vasopressin injection

USFDA gives approval for Meclizine HCL Tablets

USFDA gives nod for Prochlorperazine Maleate Tablets

USFDA gives approval generic Labetalol HCL tablets

USFDA gives final approval for Adapalene and Benzoyl Peroxide Topical Gel

IPC clarifies: General Chapter on ‘Uniformity of Dosage Units’ in IP 2022 not mandatory

USFDA gives approval for Rufinamide tablets

IPC adds 5 new IP Reference Standards & 7 new Impurities…

HP: Pharma units, Wholesalers, Chemist Shops under scanner of Anti Narcotic…

Dr VG Somani to continue as DCGI for next three months

USFDA approves generic Vasopressin injection

Drug alert: 53 out of 1337 samples declared as NSQ in July 2022

CDSCO Panel gives nod for clinical trial of Elagolix 150 mg for Endometriosis

20 Blood Banks fined ₹2.3cr for overcharging

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news